Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combined radiation and <i>Listeria</i> immunotherapy induces cytotoxic immunity that correlates with improved outcome in dogs with osteosarcoma.

Molecular therapy. Oncology·2026

Same author

Efficacy and safety evaluation of gilvetmab in dogs with melanoma and mast cell tumor.

Journal of veterinary internal medicine·2026

Same author

Distinct tumor genomic signatures underlie canine macrophage polarization.

PloS one·2026

Same author

Omacetaxine reduces c-Myc expression and demonstrates antitumor effects in osteosarcoma.

Scientific reports·2026

Same author

Critical Questions in Genomic Diagnostics for Veterinary Oncology: What We Need to Know.

Veterinary and comparative oncology·2026

Same author

Safety and Feasibility of Infusing <i>Ex Vivo</i> Expanded Allogeneic Canine Natural Killer Cells for the Treatment of Metastatic Solid Tumors.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Veterinary oncology clinical trials: design and implementation.

Douglas H Thamm¹, David M Vail²

¹Flint Animal Cancer Center, Colorado State University, 300 West Drake Road, Fort Collins, CO 80523-1620, USA.

Veterinary Journal (London, England : 1997)

|January 14, 2015

Summary

Veterinary oncology is exploring new cancer treatments for pets. This review guides the design and execution of clinical trials for novel cancer therapies in animals, informing human research.

Keywords:

Canine Clinical trial Oncology Therapeutic agents Tumor

More Related Videos

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Related Experiment Videos

Last Updated: Apr 18, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Operating Procedures of the Electrochemotherapy for Treatment of Tumor in Dogs and Cats

Published on: October 24, 2016

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

Published on: October 2, 2014

Area of Science:

Veterinary Medicine
Oncology
Translational Research

Background:

Growing interest in evaluating novel cancer therapies in pet animals with spontaneous cancer.
Includes veterinary therapeutics and agents informing human clinical trial design.
Understanding clinical evaluation stages is crucial for veterinary oncology literature interpretation.

Purpose of the Study:

To outline considerations for designing and conducting oncology clinical trials in animals.
To discuss recent adaptations in trial designs for enhanced data generation.
To provide a framework for interpreting veterinary oncology research.

Main Methods:

Review of existing methodologies in oncology clinical trial design.
Analysis of adaptations and modifications to standard trial phases.
Focus on generating timely and meaningful clinical data in veterinary oncology.

Main Results:

Provides a comprehensive overview of oncology clinical trial phases.
Highlights key considerations for trial design and conduct in veterinary patients.
Discusses innovative approaches to improve data acquisition and interpretation.

Conclusions:

Effective clinical trial design is essential for advancing veterinary oncology.
Data from pet animals can significantly inform human cancer research.
This review serves as a guide for researchers and clinicians in veterinary oncology.